T.P.46 A novel phase 2a study design to investigate drug-drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha-glucosidase in subjects with Pompe disease

✍ Scribed by Kishnani, P.; Tarnopolsky, M.; Sivakumar, K.; Byrne, B.; Goker-Alpan, O.; Guter, K.; Pervaiz, M.; Dasouki, M.; Levine, T.; Roberts, M.; Johnson, F.K.; Valenzano, K.J.; Lockhart, D.J.; Boudes, P.

• Book ID: 119333791
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 48 KB
• Volume: 22
• Category: Article
• ISSN: 0960-8966
• DOI: 10.1016/j.nmd.2012.06.165